Corresponding Author: Alex H. Krist, MD, MPH, Virginia Commonwealth University, 830 E Main St, One Capitol Square, Sixth Floor, Richmond, VA 23219 (chair@uspstf.net).
Accepted for Publication: November 3, 2020.
US Preventive Services Task Force (USPSTF) members: Alex H. Krist, MD, MPH; Karina W. Davidson, PhD, MASc; Carol M. Mangione, MD, MSPH; Michael J. Barry, MD; Michael Cabana, MD, MA, MPH; Aaron B. Caughey, MD, PhD; Katrina Donahue, MD, MPH; Chyke A. Doubeni, MD, MPH; John W. Epling Jr, MD, MSEd; Martha Kubik, PhD, RN; Gbenga Ogedegbe, MD, MPH; Douglas K. Owens, MD, MS; Lori Pbert, PhD; Michael Silverstein, MD, MPH; Melissa A. Simon, MD, MPH; Chien-Wen Tseng, MD, MPH, MSEE; John B. Wong, MD.
Affiliations of US Preventive Services Task Force (USPSTF) members: Fairfax Family Practice Residency, Fairfax, Virginia (Krist); Virginia Commonwealth University, Richmond (Krist); Feinstein Institute for Medical Research at Northwell Health, Manhasset, New York (Davidson); University of California, Los Angeles (Mangione); Harvard Medical School, Boston, Massachusetts (Barry); University of California, San Francisco (Cabana); Oregon Health & Science University, Portland (Caughey); University of North Carolina at Chapel Hill (Donahue); Mayo Clinic, Rochester, Minnesota (Doubeni); Virginia Tech Carilion School of Medicine, Roanoke (Epling Jr); George Mason University, Fairfax, Virginia (Kubik); New York University, New York, New York (Ogedegbe); Stanford University, Stanford, California (Owens); University of Massachusetts Medical School, Worcester (Pbert); Boston University, Boston, Massachusetts (Silverstein); Northwestern University, Evanston, Illinois (Simon); University of Hawaii, Honolulu (Tseng); Pacific Health Research and Education Institute, Honolulu, Hawaii (Tseng); Tufts University School of Medicine, Boston, Massachusetts (Wong).
Author Contributions: Dr Krist had full access to all of the data in the study and takes responsibility for the integrity of the data and the accuracy of the data analysis. The USPSTF members contributed equally to the recommendation statement.
Conflict of Interest Disclosures: Authors followed the policy regarding conflicts of interest described at https://www.uspreventiveservicestaskforce.org/Page/Name/conflict-of-interest-disclosures. All members of the USPSTF receive travel reimbursement and an honorarium for participating in USPSTF meetings. Dr Barry reported receiving grants and personal fees from Healthwise.
Funding/Support: The USPSTF is an independent, voluntary body. The US Congress mandates that the Agency for Healthcare Research and Quality (AHRQ) support the operations of the USPSTF.
Role of the Funder/Sponsor: AHRQ staff assisted in the following: development and review of the research plan, commission of the systematic evidence review from an Evidence-based Practice Center, coordination of expert review and public comment of the draft evidence report and draft recommendation statement, and the writing and preparation of the final recommendation statement and its submission for publication. AHRQ staff had no role in the approval of the final recommendation statement or the decision to submit for publication.
Disclaimer: Recommendations made by the USPSTF are independent of the US government. They should not be construed as an official position of AHRQ or the US Department of Health and Human Services.
Additional Contributions: We thank Iris Mabry-Hernandez, MD, MPH (AHRQ), who contributed to the writing of the manuscript, and Lisa Nicolella, MA (AHRQ), who assisted with coordination and editing.
Additional Information: The US Preventive Services Task Force (USPSTF) makes recommendations about the effectiveness of specific preventive care services for patients without obvious related signs or symptoms. It bases its recommendations on the evidence of both the benefits and harms of the service and an assessment of the balance. The USPSTF does not consider the costs of providing a service in this assessment. The USPSTF recognizes that clinical decisions involve more considerations than evidence alone. Clinicians should understand the evidence but individualize decision-making to the specific patient or situation. Similarly, the USPSTF notes that policy and coverage decisions involve considerations in addition to the evidence of clinical benefits and harms.
1.Patel
EU , Thio
CL , Boon
D , Thomas
DL , Tobian
AAR . Prevalence of hepatitis B and hepatitis D virus infections in the United States, 2011-2016.
Clin Infect Dis. 2019;69(4):709-712. doi:
10.1093/cid/ciz001PubMedGoogle ScholarCrossref 2.Schillie
S , Vellozzi
C , Reingold
A ,
et al. Prevention of hepatitis B virus infection in the United States: recommendations of the Advisory Committee on Immunization Practices.
MMWR Recomm Rep. 2018;67(1):1-31. doi:
10.15585/mmwr.rr6701a1PubMedGoogle ScholarCrossref 4.Abara
WE , Qaseem
A , Schillie
S , McMahon
BJ , Harris
AM ; High Value Care Task Force of the American College of Physicians and the Centers for Disease Control and Prevention. Hepatitis B vaccination, screening, and linkage to care: best practice advice from the American College of Physicians and the Centers for Disease Control and Prevention.
Ann Intern Med. 2017;167(11):794-804. doi:
10.7326/M17-1106PubMedGoogle ScholarCrossref 6.Lin
SY , Chang
ET , So
SK . Why we should routinely screen Asian American adults for hepatitis B: a cross-sectional study of Asians in California.
Hepatology. 2007;46(4):1034-1040. doi:
10.1002/hep.21784PubMedGoogle ScholarCrossref 9.Schweitzer
A , Horn
J , Mikolajczyk
RT , Krause
G , Ott
JJ . Estimations of worldwide prevalence of chronic hepatitis B virus infection: a systematic review of data published between 1965 and 2013.
Lancet. 2015;386(10003):1546-1555. doi:
10.1016/S0140-6736(15)61412-XPubMedGoogle ScholarCrossref 11.Chou
R , Blazina
I , Bougatsos
C ,
et al. Screening for Hepatitis B Virus Infection in Nonpregnant Adolescents and Adults: A Systematic Review for the U.S. Preventive Services Task Force Recommendation. Evidence Synthesis No. 194. Agency for Healthcare Research and Quality; 2020. AHRQ publication 20-05262-EF-1.
12.Kim
HS , Rotundo
L , Yang
JD ,
et al. Racial/ethnic disparities in the prevalence and awareness of hepatitis B virus infection and immunity in the United States.
J Viral Hepat. 2017;24(11):1052-1066. doi:
10.1111/jvh.12735PubMedGoogle ScholarCrossref 13.Weinbaum
CM , Williams
I , Mast
EE ,
et al; Centers for Disease Control and Prevention (CDC). Recommendations for identification and public health management of persons with chronic hepatitis B virus infection.
MMWR Recomm Rep. 2008;57(RR-8):1-20.
PubMedGoogle Scholar 14.Shing
JZ , Ly
KN , Xing
J , Teshale
EH , Jiles
RB . Prevalence of hepatitis B virus infection among US adults aged 20-59 years with a history of injection drug use: National Health and Nutrition Examination Survey, 2001-2016.
Clin Infect Dis. 2020;70(12):2619-2627. doi:
10.1093/cid/ciz669PubMedGoogle ScholarCrossref 15.Le
MH , Yeo
YH , Cheung
R , Henry
L , Lok
AS , Nguyen
MH . Chronic hepatitis B prevalence among foreign-born and U.S.-born adults in the United States, 1999-2016.
Hepatology. 2020;71(2):431-443. doi:
10.1002/hep.30831PubMedGoogle ScholarCrossref 19.Chou
R , Blazina
I , Bougatsos
C ,
et al. Screening for hepatitis B virus infection in nonpregnant adolescents and adults: updated evidence report and systematic review for the US Preventive Services Task Force.
JAMA. Published December 15, 2020. doi:
10.1001/jama.2020.19750Google Scholar 20.Workowski
KA , Bolan
GA ; Centers for Disease Control and Prevention. Sexually transmitted diseases treatment guidelines, 2015.
MMWR Recomm Rep. 2015;64(RR-03):1-137.
PubMedGoogle Scholar 26.Spradling
PR , Xing
J , Rupp
LB ,
et al; Chronic Hepatitis Cohort Study (CHeCS) Investigators. Infrequent clinical assessment of chronic hepatitis B patients in United States general healthcare settings.
Clin Infect Dis. 2016;63(9):1205-1208. doi:
10.1093/cid/ciw516PubMedGoogle Scholar 27.Owens
DK , Davidson
KW , Krist
AH ,
et al; US Preventive Services Task Force. Screening for hepatitis C virus infection in adolescents and adults: US Preventive Services Task Force recommendation statement.
JAMA. 2020;323(10):970-975. doi:
10.1001/jama.2020.1123PubMedGoogle ScholarCrossref 29.LeFevre
ML ; US Preventive Services Task Force. Behavioral counseling interventions to prevent sexually transmitted infections: U.S. Preventive Services Task Force recommendation statement.
Ann Intern Med. 2014;161(12):894-901. doi:
10.7326/M14-1965PubMedGoogle ScholarCrossref 30.LeFevre
ML ; US Preventive Services Task Force. Screening for hepatitis B virus infection in nonpregnant adolescents and adults: U.S. Preventive Services Task Force recommendation statement.
Ann Intern Med. 2014;161(1):58-66. doi:
10.7326/M14-1018PubMedGoogle ScholarCrossref 31.Chou
R , Dana
T , Bougatsos
C , Blazina
I , Zakher
B , Khangura
J. Screening for Hepatitis B Virus Infection in Nonpregnant Adolescents and Adults: Systematic Review to Update the 2004 U.S. Preventive Services Task Force Recommendation. Evidence Synthesis No. 110. Agency for Healthcare Research and Quality; 2014. AHRQ publication 12-05172-EF-1.